Research Article

QiangGuYin Modulates the OPG/RANKL/RANK Pathway by Increasing Secretin Levels during Treatment of Primary Type I Osteoporosis

Figure 3

Effect of QiangGuYin (QGY) treatment and secretin expression on the expression levels of RANKL, RANK, and OPG in mouse serum. (a) OPG; (b) RANKL; (c) RANK. Data are expressed as the mean ± SD (n = 6). vs. the Con group; vs. the Sec-kno group. Groups were as follows: control group (Con), secretin overexpression group (Sec-over), secretin overexpression control group (Sec-over-Con), secretin overexpression + QGY group (Sec-over + Q), secretin knockdown group (Sec-kno), secretin knockdown control group (Sec-kno-Con), and secretin knockdown + QGY group (Sec-kno + Q).
(a)
(b)
(c)